⌘K
A

Attovia Therapeutics

Healthcare & Life Sciences

Recent Finacing

Series C

Recent Raise

$90M

Attovia Therapeutics is a biopharmaceutical company developing treatments for immune-mediated diseases using its proprietary ATTOBODY platform.

Total Funding

$90M

Headquarters

San Carlos, USA

Founded

N/A

Website

attovia.com

Focus Areas

Biopharma
Immune-mediated diseases
ATTOBODY platform
Clinical-stage
Phase 1 studies

Investors

EcoR1 Capital logo
Illumina Ventures logo
Frazier Life Sciences logo
C
Deep Track Capital logo
Marshall Wace logo
Sanofi Ventures logo
Vida Ventures logo
Mirae Asset Capital Life Science logo
venBio logo
Goldman Sachs Alternatives logo
Nextech Ventures logo